At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Aug 5, 2026 at 18:59 ET
Three C-suite insiders at Nurix Therapeutics (NRIX) sold a total of $534K in open-market shares over a 7-day window, with the Chief Legal Officer accounting for $382K of that total. The sales follow option exercises and are likely liquidity-driven, but the cluster of selling by the CSO, CFO, and CLO at prices near $23-25 per share warrants attention given the stock's recent run-up and the company's $2.6B market cap. The total value is only ~0.02% of market cap, making this a routine, non-material cluster by proportionality standards.
- Three C-suite insiders sold shares: CSO Gwenn Hansen ($109K), CLO Christine Ring ($382K), and CFO Hans van Houte ($183K)
- Total open-market sales of $534K represent ~0.02% of NRIX's $2.6B market cap
- All sales followed option exercises at $0 or $1.86-$8.72 strike prices, consistent with tax-covering or liquidity-driven selling
- No insider open-market purchases were reported in the cluster window
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access